Alpha Tau and the JGH Announce Alpha DaRT Treatment of

First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable...

Related Keywords

Canada ,United States ,Montreal ,Quebec ,Jerusalem ,Israel General ,Israel ,Israeli ,Canadian ,Polytechnique Montr ,Itzhak Kelson ,Corey Miller ,Alpha Da ,Diane Cote ,Pascal Fischer ,Yona Keisari ,Miriam Santos Dutra ,Innovation In Medical Technology ,Centre For Nursing Research ,Mcgill Centre For Translational Research In Cancer ,Transmedtech Institute ,Therapeutic Endoscopy Of The Division Gastroenterology ,Terry Fox Molecular Oncology Group ,Canada First Research Excellence Fund ,Bloomfield Centre For ,Translational Research In Cancer ,Alpha Tau Medical Ltd ,Lady Davis Research Institute ,Centre For Clinical Epidemiology ,Exchange Commission ,Nasdaq ,Lady Davis Institute ,Mcgill Center ,Mcgill University ,Institute Transmedtech Dr ,Tel Aviv University ,Segal Cancer Centre ,Professor Of Medicine At Mcgill University ,Canadian Consortium For Industrial Research ,Research Communications ,Emergency Department ,Tau Medical ,Jewish General Hospital ,Uzi Sofer ,Therapeutic Endoscopy ,Assistant Professor ,Associate Researcher ,Radiation Oncology ,Mcgill Centre ,Translational Research ,Institute Transmedtech ,Alpha Tau ,Diffusing Alpha Emitters Radiation Therapy ,Tel Aviv ,Jewish General ,Intensive Care ,Neonatal Intensive Care ,Coronary Care ,Bloomfield Centre ,Clinical Epidemiology ,Community Studies ,Nursing Research ,Chief Operating ,Canadian Consortium ,Industrial Research ,Private Securities Litigation Reform Act ,United States Securities ,Nasdaq Drts ,Lpha Tau Medical Ltd ,